Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Molecular Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1107-3756 Online ISSN: 1791-244X
Journal Cover
August-2018 Volume 42 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August-2018 Volume 42 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Connexin 43 reduces susceptibility to sympathetic atrial fibrillation

Corrigendum in: /10.3892/ijmm.2020.4773
  • Authors:
    • Beibei Luo
    • Yifei Yan
    • Zhiyu Zeng
    • Zhengnan Zhang
    • Haide Liu
    • Hao Liu
    • Jinyi Li
    • Weiqiang Huang
    • Jiangtao Wu
    • Yan He
  • View Affiliations / Copyright

    Affiliations: Department of Geriatric Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530000, P.R. China, Department of Cardiology, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530000, P.R. China
  • Pages: 1125-1133
    |
    Published online on: April 30, 2018
       https://doi.org/10.3892/ijmm.2018.3648
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Atrial fibrillation (AF) is the most common arrhythmia reported in clinical practice. Connexin 43 (Cx43) is a member of the connexin protein family, which serves important roles in signal transduction in vivo. The aim of the present study was to investigate the role of Cx43 in the induction and maintenance of atrial fibrillation by using an animal model of sympathomimetic atrial fibrillation. Cx43 was successfully knocked down in the myocardium with gene‑specific small interfering (si)RNA via lentiviral infection. A total of 25 dogs were randomly and evenly divided into five groups: Normal (N), rapid atrial pacing (RAP), isoproterenol (ISO) + RAP, RAP + Cx43 siRNA and ISO + RAP + Cx43 siRNA. The mRNA and protein levels, as well as the distribution of Cx43 on the cell membrane, were gradually decreased in each group compared with the N group following treatment (P<0.05). The induction rate of the atrial effective refractory period was not significantly affected in the RAP and RAP + Cx43 siRNA groups, whereas it was significantly reduced in the ISO + RAP and ISO + RAP + Cx43 siRNA groups compared with the N group (P<0.05). The induction rate of AF was gradually increased in the RAP + Cx43 siRNA, ISO + RAP and ISO + RAP + Cx43 siRNA groups compared with the N group (P<0.05). The expression of nerve growth factor (NGF) and tyrosine hydroxylase (TH) was gradually increased in the ISO + RAP and ISO + RAP + Cx43 siRNA groups compared with their respective controls (RAP and RAP + Cx43 siRNA groups, respectively). However, no significant difference in the levels of NGF and TH was observed between the RAP, RAP + Cx43 siRNA, ISO + RAP and ISO + RAP + Cx43 siRNA groups. The mitochondrial morphology in each group was notably altered compared with the N group. The mitochondrial reactive oxygen species production and apoptotic index were gradually increased in each group compared with the N group (P<0.05). The results of the present study suggest that Cx43 reduces susceptibility to AF. Downregulation of Cx43 mediates the induction and maintenance of sympathetic AF.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

View References

1 

Lin G, Lu HH, Shen Y, Huang JF, Shi LS and Guo YN: Meta-analysis of the therapeutic effects of various methods for the treatment of chronic atrial fibrillation. Exp Ther Med. 6:489–496. 2013. View Article : Google Scholar : PubMed/NCBI

2 

Pellman J and Sheikh F: Atrial fibrillation: Mechanisms, therapeutics, and future directions. Compr Physiol. 5:649–665. 2015. View Article : Google Scholar : PubMed/NCBI

3 

Yi Z, Zhang HC, Zhang P, Liu G, Lu P, Sun JL, Liu B and Guo JH: The relationship of paroxysmal atrial fibrillation and regional sympathetic innervations in the atria and pulmonary veins: Experiment with dogs. Zhonghua Yi Xue Za Zhi. 87:pp. 3433–3435. 2007, In Chinese.

4 

Chen PS, Chen LS, Fishbein MC, Lin SF and Nattel S: Role of the autonomic nervous system in atrial fibrillation: Pathophysiology and therapy. Circ Res. 114:1500–1515. 2014. View Article : Google Scholar : PubMed/NCBI

5 

Leybaert L, Lampe PD, Dhein S, Kwak BR, Ferdinandy P, Beyer EC, Laird DW, Naus CC, Green CR and Schulz R: Connexins in cardiovascular and neurovascular health and disease: Pharmacological implications. Pharmacol Rev. 69:396–478. 2017. View Article : Google Scholar : PubMed/NCBI

6 

Del Ry S, Moscato S, Bianchi F, Morales MA, Dolfi A, Burchielli S, Cabiati M and Mattii L: Altered expression of connexin 43 and related molecular partners in a pig model of left ventricular dysfunction with and without dipyrydamole therapy. Pharmacol Res. 95–96:92–101. 2015. View Article : Google Scholar

7 

Xiao Y, Cai X, Atkinson A, Logantha SJ, Boyett M and Dobrzynski H: Expression of connexin 43, ion channels and Ca2+-handling proteins in rat pulmonary vein cardiomyocytes. Exp Ther Med. 12:3233–3241. 2016. View Article : Google Scholar : PubMed/NCBI

8 

Cai J, Jiang WG and Mansel RE: Gap junctional communication and the tyrosine phosphorylation of connexin 43 in interaction between breast cancer and endothelial cells. Int J Mol Med. 1:273–278. 1998.PubMed/NCBI

9 

Han XJ, He D, Xu LJ, Chen M, Wang YQ, Feng JG, Wei MJ, Hong T and Jiang LP: Knockdown of connexin 43 attenuates balloon injury-induced vascular restenosis through the inhibition of the proliferation and migration of vascular smooth muscle cells. Int J Mol Med. 36:1361–1368. 2015. View Article : Google Scholar : PubMed/NCBI

10 

Brockmeyer P, Jung K, Perske C, Schliephake H and Hemmerlein B: Membrane connexin 43 acts as an independent prognostic marker in oral squamous cell carcinoma. Int J Oncol. 45:273–281. 2014. View Article : Google Scholar : PubMed/NCBI

11 

Han XJ, Chen M, Hong T, Zhu LY, He D, Feng JG and Jiang LP: Lentivirus-mediated RNAi knockdown of the gap junction protein, Cx43, attenuates the development of vascular restenosis following balloon injury. Int J Mol Med. 35:885–892. 2015. View Article : Google Scholar : PubMed/NCBI

12 

Brockmeyer P, Hemmerlein B, Jung K, Fialka F, Brodmann T, Gruber RM, Schliephake H and Kramer FJ: Connexin subtype expression during oral carcinogenesis: A pilot study in patients with oral squamous cell carcinoma. Mol Clin Oncol. 4:298–302. 2016. View Article : Google Scholar : PubMed/NCBI

13 

Wang Y, Wu Z, Liu X and Fu Q: Gastrodin ameliorates Parkinsons disease by downregulating connexin 43. Mol Med Rep. 8:585–590. 2013. View Article : Google Scholar : PubMed/NCBI

14 

Yi S, Chen Y, Wen L, Yang L and Cui G: Expression of connexin 32 and connexin 43 in acute myeloid leukemia and their roles in proliferation. Oncol Lett. 4:1003–1007. 2012. View Article : Google Scholar : PubMed/NCBI

15 

Sun Y, Zhao X, Yao Y, Qi X, Yuan Y and Hu Y: Connexin 43 interacts with Bax to regulate apoptosis of pancreatic cancer through a gap junction-independent pathway. Int J Oncol. 41:941–948. 2012. View Article : Google Scholar : PubMed/NCBI

16 

Fukushima M, Hattori Y, Yoshizawa T and Maitani Y: Combination of non-viral connexin 43 gene therapy and docetaxel inhibits the growth of human prostate cancer in mice. Int J Oncol. 30:225–231. 2007.

17 

Yan Y, Huang J, Ding F, Mei J, Zhu J, Liu H and Sun K: Aquaporin 1 plays an important role in myocardial edema caused by cardiopulmonary bypass surgery in goat. Int J Mol Med. 31:637–643. 2013. View Article : Google Scholar : PubMed/NCBI

18 

Boengler K and Schulz R: Connexin 43 and mitochondria in cardiovascular health and disease. Adv Exp Med Biol. 982:227–246. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Sovari AA, Rutledge CA, Jeong EM, Dolmatova E, Arasu D, Liu H, Vahdani N, Gu L, Zandieh S, Xiao L, et al: Mitochondria oxidative stress, connexin43 remodeling, and sudden arrhythmic death. Circ Arrhythm Electrophysiol. 6:623–631. 2013. View Article : Google Scholar : PubMed/NCBI

20 

Duffy HS and Wit AL: Is there a role for remodeled connexins in AF? No simple answers J Mol Cell Cardiol. 44:4–13. 2008. View Article : Google Scholar

21 

Shu C, Huang W, Zeng Z, He Y, Luo B, Liu H, Li J and Xu J: Connexin 43 is involved in the sympathetic atrial fibrillation in canine and canine atrial myocytes. Anatol J Cardiol. 18:3–9. 2017.PubMed/NCBI

22 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar

23 

Volders PG: Novel insights into the role of the sympathetic nervous system in cardiac arrhythmogenesis. Heart Rhythm. 7:1900–1906. 2010. View Article : Google Scholar : PubMed/NCBI

24 

Yu L, Li X, Huang B, Zhou X, Wang M, Zhou L, Meng G, Wang Y, Wang Z, Deng J and Jiang H: Atrial fibrillation in acute obstructive sleep apnea: Autonomic nervous mechanism and modulation. J Am Heart Assoc. 6:2017. View Article : Google Scholar

25 

Li Y, Lu Z, Tang Q, Jiang H, Huang C, He B, Hu X, Huang J, Zhu X and Wang H: The increase in sympathetic nerve density in the atrium facilitates atrial fibrillation in patients with rheumatic heart disease. Int J Cardiol. 165:174–178. 2013. View Article : Google Scholar

26 

Zhang L, Po SS, Wang H, Scherlag BJ, Li H, Sun J, Lu Y, Ma Y and Hou Y: Autonomic remodeling: How atrial fibrillation begets atrial fibrillation in the first 24 hours. J Cardiovasc Pharmacol. 66:307–315. 2015. View Article : Google Scholar : PubMed/NCBI

27 

Saygili E, Rana OR, Gunzel C, Günzel C, Rackauskas G, Saygili E, Noor-Ebad F, Gemein C, Zink MD, Schwinger RH, Mischke K, et al: Rate and irregularity of electrical activation during atrial fibrillation affect myocardial NGF expression via different signalling routes. Cell Signal. 24:99–105. 2012. View Article : Google Scholar

28 

Ribeiro-Rodrigues TM, Martins-Marques T, Morel S, Kwak BR and Girão H: Role of connexin 43 in different forms of intercellular communication-gap junctions, extracellular vesicles and tunnelling nanotubes. J Cell Sci. 130:3619–3630. 2017. View Article : Google Scholar : PubMed/NCBI

29 

Palatinus JA, Rhett JM and Gourdie RG: The connexin43 carboxyl terminus and cardiac gap junction organization. Biochim Biophys Acta. 1818:1831–1843. 2012. View Article : Google Scholar

30 

Lee HC: Electrical remodeling in human atrial fibrillation. Chin Med J. 126:2380–2383. 2013.PubMed/NCBI

31 

Nagibin V, Egan Benova T, Viczenczova C, Szeiffova Bacova B, Dovinova I, Barancik M and Tribulova N: Ageing related down-regulation of myocardial connexin-43 and up-regulation of MMP-2 may predict propensity to atrial fibrillation in experimental animals. Physiol Res. 65(Suppl 1): S91–S100. 2016.PubMed/NCBI

32 

Davel AP, Brum PC and Rossoni LV: Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Gialpha-coupled β2-adrenoceptor signaling pathway. PloS One. 9:e918772014. View Article : Google Scholar

33 

Kumar M, Kasala ER, Bodduluru LN, Dahiya V and Lahkar M: Baicalein protects isoproterenol induced myocardial ischemic injury in male Wistar rats by mitigating oxidative stress and inflammation. Inflamm Res. 65:613–622. 2016. View Article : Google Scholar : PubMed/NCBI

34 

Yin Q, Lu H, Bai Y, Tian A, Yang Q, Wu J, Yang C, Fan TP, Zhang Y, Zheng X, et al: A metabolite of Danshen formulae attenuates cardiac fibrosis induced by isoprenaline, via a NOX2/ROS/p38 pathway. Br J Pharmacol. 172:5573–5585. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Lenaerts I, Driesen RB, Hermida N, Holemans P, Heidbüchel H, Janssens S, Balligand JL, Sipido KR and Willems R: Role of nitric oxide and oxidative stress in a sheep model of persistent atrial fibrillation. Europace. 15:754–760. 2013. View Article : Google Scholar : PubMed/NCBI

36 

Zhou P, Zhang SM, Wang QL, Wu Q, Chen M and Pei JM: Anti-arrhythmic effect of verapamil is accompanied by preservation of cx43 protein in rat heart. PloS One. 8:e715672013. View Article : Google Scholar : PubMed/NCBI

37 

Adam O, Lavall D, Theobald K, Hohl M, Grube M, Ameling S, Sussman MA, Rosenkranz S, Kroemer HK, Schäfers HJ, et al: Rac1-induced connective tissue growth factor regulates connexin 43 and N-cadherin expression in atrial fibrillation. J Am Coll Cardiol. 55:469–480. 2010. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Luo B, Yan Y, Zeng Z, Zhang Z, Liu H, Liu H, Li J, Huang W, Wu J, He Y, He Y, et al: Connexin 43 reduces susceptibility to sympathetic atrial fibrillation Corrigendum in /10.3892/ijmm.2020.4773. Int J Mol Med 42: 1125-1133, 2018.
APA
Luo, B., Yan, Y., Zeng, Z., Zhang, Z., Liu, H., Liu, H. ... He, Y. (2018). Connexin 43 reduces susceptibility to sympathetic atrial fibrillation Corrigendum in /10.3892/ijmm.2020.4773. International Journal of Molecular Medicine, 42, 1125-1133. https://doi.org/10.3892/ijmm.2018.3648
MLA
Luo, B., Yan, Y., Zeng, Z., Zhang, Z., Liu, H., Liu, H., Li, J., Huang, W., Wu, J., He, Y."Connexin 43 reduces susceptibility to sympathetic atrial fibrillation Corrigendum in /10.3892/ijmm.2020.4773". International Journal of Molecular Medicine 42.2 (2018): 1125-1133.
Chicago
Luo, B., Yan, Y., Zeng, Z., Zhang, Z., Liu, H., Liu, H., Li, J., Huang, W., Wu, J., He, Y."Connexin 43 reduces susceptibility to sympathetic atrial fibrillation Corrigendum in /10.3892/ijmm.2020.4773". International Journal of Molecular Medicine 42, no. 2 (2018): 1125-1133. https://doi.org/10.3892/ijmm.2018.3648
Copy and paste a formatted citation
x
Spandidos Publications style
Luo B, Yan Y, Zeng Z, Zhang Z, Liu H, Liu H, Li J, Huang W, Wu J, He Y, He Y, et al: Connexin 43 reduces susceptibility to sympathetic atrial fibrillation Corrigendum in /10.3892/ijmm.2020.4773. Int J Mol Med 42: 1125-1133, 2018.
APA
Luo, B., Yan, Y., Zeng, Z., Zhang, Z., Liu, H., Liu, H. ... He, Y. (2018). Connexin 43 reduces susceptibility to sympathetic atrial fibrillation Corrigendum in /10.3892/ijmm.2020.4773. International Journal of Molecular Medicine, 42, 1125-1133. https://doi.org/10.3892/ijmm.2018.3648
MLA
Luo, B., Yan, Y., Zeng, Z., Zhang, Z., Liu, H., Liu, H., Li, J., Huang, W., Wu, J., He, Y."Connexin 43 reduces susceptibility to sympathetic atrial fibrillation Corrigendum in /10.3892/ijmm.2020.4773". International Journal of Molecular Medicine 42.2 (2018): 1125-1133.
Chicago
Luo, B., Yan, Y., Zeng, Z., Zhang, Z., Liu, H., Liu, H., Li, J., Huang, W., Wu, J., He, Y."Connexin 43 reduces susceptibility to sympathetic atrial fibrillation Corrigendum in /10.3892/ijmm.2020.4773". International Journal of Molecular Medicine 42, no. 2 (2018): 1125-1133. https://doi.org/10.3892/ijmm.2018.3648
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team